Gene symbol | TP53 | Synonyms | BCC7, BMFS5, LFS1, P53, TRP53 | Type of gene | protein-coding |
Chromosome | 17 | Map location | 17p13.1 | dbXrefs | |
Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
Description | tumor protein p53 |
GTO ID | GTC1492 |
Trial ID | NCT02243124 |
Disease | Myelodysplastic Syndrome |
Altered gene | P53 |
Therapeutic/Target gene | Target gene |
Therapy | ASO |
Treatment | Aezea|Cenersen|EL625|Ol(1)p53 |
Co-treatment | Dexamethasone |
Phase | Phase1 |
Recruitment status | Terminated |
Title | A Study of Aezea (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome |
Year | 2014 |
Country | United States |
Company sponsor | Eleos, Inc. |
Other ID(s) | MDS ELP9001 |
Vector information | |||
|
Cohort1: dose level 1 | |||||||
|
|||||||
Cohort2: dose level 2 | |||||||
|
|||||||
Cohort3: dose level 3 | |||||||
|